Tradestie Institutional Equity Comparison Engine
XBIO vs FEED โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
XBIO Overall Edge
XBIO Captures Institutional Edge (2โ0 Pillars ยท 7โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Xenetic Biosciences, Inc. (XBIO) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, XBIO trades at N/M Forward P/E with -81.0% operating margin (+12.0% YoY revenue) versus FEED at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, XBIO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against FEED sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
XBIO N/M vs FEED N/M Fwd P/E
Growth & Margin Winner
XBIO
Op Margin -81.0% vs N/A ยท YoY +12.0% vs N/A
Momentum & Technical Winner
XBIO
1Y -44.9% vs -75.3% ยท 52W Pos 4% vs 13%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
XBIO
NASDAQ
Xenetic Biosciences, Inc.
Pharmaceutical Preparations
$1.40
-9.09% 1D
Market Cap
$3.6M
1M Return
-27.46%
1Y Return
-44.88%
Forward P/E
N/M
Unified AI Score
43.5 / 100
HOLD
Tech 25.0
Fund 56.0
Flow 50.0
Mom 55.0
FEED
US Equity
FEED
Institutional Equity
$1.03
-69.25% 1D
Market Cap
N/A
1M Return
+135.7%
1Y Return
-75.27%
Forward P/E
N/M
Unified AI Score
37.1 / 100
SELL
Tech 15.0
Fund 28.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
XBIO -44.88%
FEED -75.27%
Spread: +150.99 pp (XBIO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
XBIO TTM Op. Margin: -81.0%
FEED TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XBIO vs FEED. Trailing 12-month operating profitability (XBIO -81.0% vs FEED N/A) and valuation multiples (XBIO N/M vs FEED N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | XBIO | FEED | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.6M | N/A | Larger Scale | XBIO |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +12.0% | N/A | Higher Growth | XBIO |
| Operating Margin (TTM) Profitability | -81.0% | N/A | Higher Margin | XBIO |
| Net Profit Margin Profitability | -75.9% | N/A | Higher Margin | XBIO |
| Return on Equity (ROE) Capital Efficiency | -47.0% | N/A | Higher ROE | XBIO |
| 52-Week Range Position Momentum | 4% ($1โ$5) | 13% ($0โ$6) | Stronger Trend | FEED |
| Beta / 30D Volatility Risk Regime | 1.40ฮฒ ยท 99% Vol | -6.40ฮฒ ยท 3942% Vol | Lower Realized Risk | XBIO |
| Unified Institutional Score Composite Signal | 43.5 / 100 (HOLD) | 37.1 / 100 (SELL) | Higher Composite | XBIO |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full XBIO vs FEED Buy Guide
XBIO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
FEED
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither XBIO nor FEED registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.